PCP
EHC icon

Perbak Capital Partners’s Encompass Health EHC Stock Holding History

Perbak Capital Partners’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-13,183
Closed -$1.22M – 196
2024
Q4 		$1.22M Buy
13,183
+3,909
+42% +$384K 0.65% 40
2024
Q3 		$896K Sell
9,274
-69,177
-88% -$6.22M 0.63% 27
2024
Q2 		$6.73M Buy
+78,451
New +$6.58M 1.99% 10

Other funds holding EHC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Perbak Capital Partners's EHC Position: Q1 2025 in Review

Perbak Capital Partners sold out of Encompass Health (EHC) in Q1 2025, closing a stake of 13,183 shares — an estimated $1.22M sold.

Perbak Capital Partners first reported a position in EHC in Q2 2024 and held it in 3 quarters. The position peaked at $6.73M in Q2 2024. 537 funds tracked by Wall St. Rank hold EHC as of Q1 2025.

  • Perbak Capital Partners reported no remaining Encompass Health position as of Q1 2025 after selling out during the quarter.
  • Perbak Capital Partners sold 13,183 Encompass Health shares in Q1 2025, an estimated $1.22M.
  • Perbak Capital Partners first reported a position in Encompass Health in Q2 2024 and held it in 3 quarters.
  • Perbak Capital Partners's Encompass Health position peaked at $6.73M in Q2 2024.
  • 537 funds tracked by Wall St. Rank held Encompass Health as of Q1 2025.

Based on Perbak Capital Partners's 13F filing for Q1 2025, filed 15 May 2025.